Intercept to Present at Upcoming Investor Conferences
September 02 2016 - 7:30AM
Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical
company focused on the development and commercialization of novel
therapeutics to treat non-viral, progressive liver diseases, today
announced management will be participating in the following
investor conferences:
- Baird 2016 Global Healthcare Conference on September 8, 2016 at
2:35 p.m. Eastern Time
- Morgan Stanley Global Healthcare Conference on September 13,
2016 at 1:30 p.m. Eastern Time
Webcast information for these events will be available on the
Investors page of Intercept's website at
http://ir.interceptpharma.com. Archived webcasts will be available
on Intercept's website for approximately two weeks.
About InterceptIntercept is a biopharmaceutical
company focused on the development and commercialization of novel
therapeutics to treat non-viral, progressive liver diseases,
including primary biliary cholangitis (PBC), nonalcoholic
steatohepatitis (NASH), primary sclerosing cholangitis (PSC) and
biliary atresia. Founded in 2002 in New York, Intercept now has
operations in the United States, Europe and Canada.
CONTACT:
For more information about
Intercept Pharmaceuticals, please contact:
Intercept Pharmaceuticals:
Mark Vignola
+1-646-747-1000
investors@interceptpharma.com
Media inquiries: media@interceptpharma.com
Investor inquiries: investors@interceptpharma.com
Intercept Pharmaceuticals (NASDAQ:ICPT)
Historical Stock Chart
From Apr 2024 to May 2024
Intercept Pharmaceuticals (NASDAQ:ICPT)
Historical Stock Chart
From May 2023 to May 2024